BCAX

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 6

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,497

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.68 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 5

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,403

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 4

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,497

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.68 to $19.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 3

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,091

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · derivative · entry 6

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,184

Underlying: Common Stock · 17,795 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · nonDerivative · entry 4

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · nonDerivative · entry 3

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,150

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034671-25-000009 · wk-form4_1764114037.xml · derivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 236,107

Underlying: Common Stock · 41,163 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034671-25-000009 · wk-form4_1764114037.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,892

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $18.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034671-25-000009 · wk-form4_1764114037.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 351,055

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · derivative · entry 7

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,370

Underlying: Common Stock · 5,500 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: 25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 2

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,497

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034679-25-000006 · wk-form4_1764113985.xml · nonDerivative · entry 1

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 40,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034665-25-000009 · wk-form4_1764114091.xml · derivative · entry 4

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 149,334

Underlying: Common Stock · 8,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034665-25-000009 · wk-form4_1764114091.xml · nonDerivative · entry 3

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 193,641

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000009 · wk-form4_1764114091.xml · nonDerivative · entry 2

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,141

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000009 · wk-form4_1764114091.xml · nonDerivative · entry 1

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 206,141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · derivative · entry 5

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 115,979

Underlying: Common Stock · 605 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · nonDerivative · entry 2

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034668-25-000010 · wk-form4_1764114131.xml · nonDerivative · entry 1

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,960

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034671-25-000006 · wk-form4_1760991057.xml · derivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 277,270

Underlying: Common Stock · 24,103 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034671-25-000006 · wk-form4_1760991057.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,892

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.17, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034671-25-000006 · wk-form4_1760991057.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 333,995

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · derivative · entry 6

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 301,373

Underlying: Common Stock · 13,289 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · nonDerivative · entry 4

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,892

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $18.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · nonDerivative · entry 3

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 323,181

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034665-25-000006 · wk-form4_1760647298.xml · derivative · entry 4

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,334

Underlying: Common Stock · 8,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034665-25-000006 · wk-form4_1760647298.xml · nonDerivative · entry 3

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 198,141

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000006 · wk-form4_1760647298.xml · nonDerivative · entry 2

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202,641

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000006 · wk-form4_1760647298.xml · nonDerivative · entry 1

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,641

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · derivative · entry 5

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 314,662

Underlying: Common Stock · 11,445 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · nonDerivative · entry 2

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 309,892

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.73 to $19.635, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034671-25-000003 · wk-form4_1760565614.xml · nonDerivative · entry 1

Mazumdar Claire · CIK 0002034671 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 321,337

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034668-25-000007 · wk-form4_1760131373.xml · derivative · entry 3

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 116,584

Underlying: Common Stock · 6,415 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034668-25-000007 · wk-form4_1760131373.xml · nonDerivative · entry 2

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034668-25-000007 · wk-form4_1760131373.xml · nonDerivative · entry 1

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 151,770

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034679-25-000003 · wk-form4_1760131397.xml · derivative · entry 3

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,870

Underlying: Common Stock · 22,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F2 · derivative.exercise_date: 25% of the shares underlying this option vested on July 24, 2024, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034679-25-000003 · wk-form4_1760131397.xml · nonDerivative · entry 2

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 35,497

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034679-25-000003 · wk-form4_1760131397.xml · nonDerivative · entry 1

Raben David · CIK 0002034679 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 57,497

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · derivative · entry 9

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 122,999

Underlying: Common Stock · 5,627 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · nonDerivative · entry 6

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · nonDerivative · entry 5

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,982

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034665-25-000004 · wk-form4_1759959205.xml · derivative · entry 8

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,334

Underlying: Common Stock · 8,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034665-25-000004 · wk-form4_1759959205.xml · nonDerivative · entry 6

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 202,641

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000004 · wk-form4_1759959205.xml · nonDerivative · entry 5

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 205,541

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.00 to $18.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034665-25-000004 · wk-form4_1759959205.xml · nonDerivative · entry 4

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 213,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · derivative · entry 8

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,626

Underlying: Common Stock · 18,244 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · nonDerivative · entry 4

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 145,355

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $18.15 to $18.36, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.

SEC source: 0002034668-25-000004 · wk-form4_1759959228.xml · nonDerivative · entry 3

Hyep Ivan · CIK 0002034668 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 163,599

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025.

SEC source: 0002034665-25-000004 · wk-form4_1759959205.xml · derivative · entry 7

Cohlhepp Ryan · CIK 0002034665 · Director · President and COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 173,334

Underlying: Common Stock · 24,000 shares

Expires 2033-08-08

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on February 12, 2025.

F4 · derivative.exercise_date: The shares underlying this option vest in sixteen equal quarterly installments following August 8, 2023, subject to the Reporting Person's continued service on each such vesting date.